FDA Says CBD-THC Drug for Bone Cancer Pain in Dogs Can Pursue Conditional Approval Pathway

The Marijuana Herald
By Anthony MartinelliOct 5, 2026, 3:39 pm70 pts
The Marijuana Herald - Marijuana news and information The U.S. Food and Drug Administration (FDA) has determined that a CBD- and THC-based drug being developed to control bone cancer pain in dogs qualifies for a regulatory pathway that could allow it to reach the market before receiving full approval. Endovia…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Vanquish Medical Brings Craft Cannabis to Canadian Patients 79

Minnesota Has Issued Nearly 400 Marijuana Business Licenses, With 223 Adult-Use Retail Sites Now Licensed 78

FDA Says CBD-THC Drug for Bone Cancer Pain in Dogs Can Pursue Conditional Approval Pathway 69

Increase In Marijuana Misuse Diagnoses Among Veterans Is More Complicated Than It Looks, VA Records Reveal (Op-Ed) 62

How the federal hemp ban treats delta-8 THC differently – and what operators are doing 59

Why are marijuana multistate operators supporting an anti-marijuana Senate candidate? 55

Why are marijuana multistate operators supporting an anti-marijuana Senate candidate? 32

NJCRC Suspends Magic Garden Botanicals Cultivation License at Special Meeting

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.